← ANALYST RATINGS · TIPRANKS
Context Therapeutics (CNTX): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Strong Buy5 Buy1 Hold0 Sell
Ratings of 6 analysts in the last 3 months12-month forecast
$3.20+1,211.5% upside
Based on 6 price targets given in the last 3 months, the average target is $3.20, the highest $5.00, the lowest $2.00. The average is +1,211.5% from the last price of $0.24.
Highest target $5.00
Average target $3.20
Lowest target $2.00
Analyst ratings 8
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.24 → $0.23−4.1% | Hold | −4.9% | Upgrade | 16.10.26on TipRanks 02:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.24 → $0.23−4.6% | Sell | −7.0% | Reiterated | 16.10.26on TipRanks 02:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.25 → $0.23−7.3% | Hold | −6.1% | Reiterated | 16.10.26on TipRanks 02:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.24 → $0.22−11.0% | Sell | −10.7% | Downgrade | 16.10.26on TipRanks 02:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.24 → $0.23−6.2% | Sell | −7.4% | Reiterated | 16.10.26on TipRanks 02:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.25 → $0.23−7.7% | Sell | −6.6% | Downgrade | 16.10.26on TipRanks 02:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.26 → $0.24−7.3% | Sell | −0.8% | Downgrade | 15.10.26on TipRanks 17:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.26 → $0.24−7.4% | Sell | −2.5% | Downgrade | 15.10.26on TipRanks 17:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.27 → $0.25−7.1% | Hold | +1.2% | Reiterated | 15.10.26on TipRanks 17:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.26 → $0.24−7.2% | Hold | +0.4% | Upgrade | 15.10.26on TipRanks 17:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.26 → $0.24−7.3% | Sell | −1.2% | Downgrade | 15.10.26on TipRanks 17:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.27 → $0.25−7.5% | Hold | +1.2% | Upgrade | 15.10.26on TipRanks 17:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.29 → $0.26−10.0% | Sell | +7.0% | Downgrade | 14.10.26on TipRanks 10:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.28 → $0.26−9.8% | Sell | +5.3% | Downgrade | 14.10.26on TipRanks 10:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.29 → $0.27−9.8% | Hold | +9.0% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.29 → $0.26−9.9% | Hold | +8.2% | Upgrade | 14.10.26on TipRanks 10:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.29 → $0.26−9.7% | Sell | +6.6% | Downgrade | 14.10.26on TipRanks 10:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.30 → $0.27−9.8% | Hold | +9.4% | Upgrade | 14.10.26on TipRanks 10:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.29 | Sell | +18.9% | Downgrade | 13.10.26on TipRanks 01:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.28 | Sell | +16.8% | Downgrade | 13.10.26on TipRanks 01:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.29 | Hold | +20.9% | Reiterated | 13.10.26on TipRanks 01:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.29 | Hold | +20.1% | Upgrade | 13.10.26on TipRanks 01:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.29 | Sell | +18.0% | Downgrade | 13.10.26on TipRanks 01:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.30 | Hold | +21.3% | Upgrade | 13.10.26on TipRanks 01:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.28 → $0.29+1.8% | Sell | +18.4% | Downgrade | 11.10.26on TipRanks 20:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.28 | Sell | +16.4% | Downgrade | 11.10.26on TipRanks 20:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.29 → $0.29+1.7% | Hold | +20.5% | Reiterated | 11.10.26on TipRanks 20:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.29 → $0.29+1.7% | Hold | +19.7% | Upgrade | 11.10.26on TipRanks 20:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.29 | Sell | +17.6% | Downgrade | 11.10.26on TipRanks 20:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.29 → $0.29+1.7% | Hold | +20.9% | Upgrade | 11.10.26on TipRanks 20:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.30 → $0.28−4.1% | Sell | +16.4% | Downgrade | 09.10.26on TipRanks 11:06 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.29 → $0.28−4.1% | Sell | +14.8% | Downgrade | 09.10.26on TipRanks 11:06 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.30 → $0.29−4.3% | Hold | +18.4% | Reiterated | 09.10.26on TipRanks 11:06 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.30 → $0.29−4.3% | Hold | +17.6% | Upgrade | 09.10.26on TipRanks 11:06 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.29 → $0.28−4.1% | Sell | +16.0% | Downgrade | 09.10.26on TipRanks 11:06 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.30 → $0.29−4.3% | Hold | +18.9% | Upgrade | 09.10.26on TipRanks 11:06 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.30 | Sell | +21.3% | Downgrade | 08.10.26on TipRanks 10:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.29 | Sell | +19.7% | Downgrade | 08.10.26on TipRanks 10:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.30 | Hold | +23.8% | Reiterated | 08.10.26on TipRanks 10:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.30 | Hold | +23.0% | Upgrade | 08.10.26on TipRanks 10:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.29 | Sell | +20.9% | Downgrade | 08.10.26on TipRanks 10:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.30 | Hold | +24.2% | Upgrade | 08.10.26on TipRanks 10:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.29 | Sell | +20.5% | Downgrade | 03.10.26on TipRanks 06:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.29 → $0.29−1.7% | Sell | +18.4% | Downgrade | 03.10.26on TipRanks 06:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.30 → $0.30−1.6% | Hold | +22.5% | Reiterated | 03.10.26on TipRanks 06:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.30 | Hold | +21.7% | Upgrade | 03.10.26on TipRanks 06:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.30 → $0.29−1.7% | Sell | +19.7% | Downgrade | 03.10.26on TipRanks 06:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.30 → $0.30−1.6% | Hold | +23.0% | Upgrade | 03.10.26on TipRanks 06:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.28 → $0.30+4.6% | Sell | +22.1% | Downgrade | 02.10.26on TipRanks 05:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.28 → $0.29+4.6% | Sell | +20.5% | Downgrade | 02.10.26on TipRanks 05:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.29 → $0.30+4.8% | Hold | +24.6% | Reiterated | 02.10.26on TipRanks 05:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.29 → $0.30+4.5% | Hold | +23.4% | Upgrade | 02.10.26on TipRanks 05:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.28 → $0.30+4.6% | Sell | +21.7% | Downgrade | 02.10.26on TipRanks 05:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.29 → $0.30+4.8% | Hold | +25.0% | Upgrade | 02.10.26on TipRanks 05:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.33 → $0.28−14.4% | Sell | +16.8% | Downgrade | 01.10.26on TipRanks 04:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.33 → $0.28−14.1% | Sell | +15.2% | Downgrade | 01.10.26on TipRanks 04:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.34 → $0.29−14.5% | Hold | +18.9% | Reiterated | 01.10.26on TipRanks 04:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.34 → $0.29−14.3% | Hold | +18.0% | Upgrade | 01.10.26on TipRanks 04:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.33 → $0.28−14.2% | Sell | +16.4% | Downgrade | 01.10.26on TipRanks 04:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.34 → $0.29−14.4% | Hold | +19.3% | Upgrade | 01.10.26on TipRanks 04:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.36 → $0.33−7.2% | Sell | +36.5% | Downgrade | 12.09.26on TipRanks 07:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.35 → $0.33−7.4% | Sell | +34.0% | Downgrade | 12.09.26on TipRanks 07:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.36 → $0.34−5.0% | Hold | +38.9% | Reiterated | 12.09.26on TipRanks 07:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.35 → $0.34−3.4% | Hold | +37.7% | Upgrade | 12.09.26on TipRanks 07:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.35 → $0.33−6.2% | Sell | +35.7% | Downgrade | 12.09.26on TipRanks 07:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.34 | Hold | +39.3% | Upgrade | 12.09.26on TipRanks 07:05 | — | |
| Jason McCarthy★★★★★★★★★★#12398 · hits 30% · avg −13.6% | Maxim Group | $4.00 | Buy | +1,539.3% | Reiterated | 10.08.26on TipRanks Aug 11 15:55 | −6.6%next day +3.2% · 5 days +17.3% | ↗ |
| Charles Zhu★★★★★★★★★★#351 · hits 64% · avg +25.8% | LifeSci Capital | $2.00 | Hold | +719.7% | Downgrade | 08.08.26on TipRanks Aug 6 16:37 | −4.6%next day −6.6% · 5 days +7.5% | ↗ |
| Silvan Turkcan★★★★★★★★★★#10721 · hits 17% · avg −13.5% | Citizens JMP | $4.00 → $3.00−25.0% | Buy | +1,129.5% | Reiterated | 06.08.26on TipRanks 15:30 | −27.1%next day −4.6% · 5 days −0.8% | ↗ |
| Matt Phipps★★★★★★★★★★#2652 · hits 48% · avg +4.8% | William Blair | — | Buy | — | Reiterated | 06.08.26on TipRanks 09:15 | −27.1%next day −4.6% · 5 days −0.8% | ↗ |
| Boris Peaker★★★★★★★★★★#357 · hits 49% · avg +22.6% | JonesTrading | $7.00 → $2.00−71.4% | Buy | +719.7% | Reiterated | 06.08.26on TipRanks 08:50 | −27.1%next day −4.6% · 5 days −0.8% | ↗ |
| Emily Bodnar★★★★★★★★★★#2140 · hits 39% · avg +7.2% | H.C. Wainwright | $5.00 | Buy | +1,949.2% | Reiterated | 06.08.26on TipRanks 06:25 | −27.1%next day −4.6% · 5 days −0.8% | ↗ |
| Biren Amin★★★★★★★★★★#1671 · hits 46% · avg +7.6% | Piper Sandler | $7.00 | Buy | +2,768.9% | Reiterated | 02.06.26on TipRanks 07:15 | −13.4%next day −14.6% · 5 days −34.2% | ↗ |
| Paul Jeng★★★★★★★★★★#9457 · hits 52% · avg −1.9% | Guggenheim | $5.00 | Buy | +1,949.2% | Reiterated | 06.05.26on TipRanks May 7 07:00 | −2.6%next day −3.0% · 5 days −3.2% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Context Therapeutics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $3.20 at a price of $0.30 (+966.7%); now: $3.20 at $0.24 (+1,211.5%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 20 | 15 | 10 | 4 | 4 |
| Buy | 4 | 4 | 3 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 11.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.11 (from $-0.16 to $-0.07). Last quarter: $-0.15.
Best top-analyst consensus in the sector · Healthcare
About Context Therapeutics
- CEO: Martin A. Lehr
- Employees: 15
- 2001 Market Street, Philadelphia, PA, 19103, US
- www.contexttherapeutics.com
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Data from the stock’s TipRanks forecast page, read 29 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗